Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 15,520 | 14,393 | 9,945 | 9,575 | 5,925 |
| Operating Income | -15,520 | -14,393 | -9,945 | -9,575 | -5,925 |
| Other Income | 1,606 | 1,637 | 1,016 | 377 | 105 |
| Pre-tax Income | -13,914 | -12,756 | -8,929 | -9,198 | -5,820 |
| Net Income Continuous | -13,914 | -12,756 | -8,929 | -9,198 | -5,820 |
| Net Income | $-13,914 | $-12,756 | $-8,929 | $-9,198 | $-5,820 |
| EPS Basic Total Ops | -0.63 | -0.58 | 4.98 | -5.17 | -3.29 |
| EPS Basic Continuous Ops | -0.63 | -0.58 | 4.98 | -5.17 | -3.29 |
| EPS Diluted Total Ops | -0.63 | -0.58 | 4.98 | -5.17 | -3.29 |
| EPS Diluted Continuous Ops | -0.63 | -0.58 | 4.98 | -5.17 | -3.29 |
| EPS Diluted Before Non-Recurring Items | -0.63 | -0.58 | -0.80 | -5.17 | N/A |
| EBITDA(a) | $-16,159 | $-15,401 | $-10,336 | $-9,641 | $-5,847 |